Gene Editing: Fine Scale vs. Large Scale Explained Simply Explained! #shorts

Distinguishing between fine-scale genetic scalpels and large-scale insertion of kilobase genetic payloads. The latter, the focus of Profluent's Lilly deal, enables whole genetic sequences to be integrated into the human genome. #GeneEditing #crisproducciones Profluent just signed a $2.25B partnership with Eli Lilly to develop AI-designed gene editors - one of the largest deals to date between a frontier AI biology lab and big pharma. It capped a huge few weeks for AI in bio, alongside Verve's base-editing data, new scaling results on protein models, and Isomorphic Labs' latest raise. Profluent: https://www.profluent.bio Air Street Capital: https://www.airstreet.com Follow Ali: https://x.com/thisismadani Follow Nathan: https://x.com/nathanbenaich